ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Collection of Samples and Data for the National Marrow Donor Program Repository

This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), April 2008

Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00495300
  Purpose

This protocol will collect blood samples and medical information from patients who have had a bone marrow transplant using cells from an unrelated donor identified through the National Marrow Donor Program (NMDP). The NMDP has two programs in which patients can participate: the Research Database Program and the Research Sample Repository.

Patients who have received a bone marrow transplant at the NIH or other institution from an unrelated donor affiliated with the NMDP may be eligible for this study.

Participants in the NMDP Research Database program will have medical information about their disease and their transplant sent to the NMDP before and after the transplant and once a year for the rest of their life. The information will be used to help determine how well transplant recipients recover from their transplant, how recovery after a transplant can be improved, how access to transplant for different groups of patients can be improved and how well donors recover from collection procedures.

Participants in the NMDP Research Sample Repository program will have a small blood sample drawn from a vein in the arm just before they start taking medicines for the conditioning regimen to prepare them for the transplant. The blood samples will be used to look at ways to improve how patients are matched with their donors, to determine and evaluate the factors that affect transplant outcome, and to help develop methods to improve tissue matching between donors and recipients....


Condition
Hematopoietic Stem Cell Transplantation

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   The Collection of Research Samples and/or Data for Repository From Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   500
Study Start Date:   June 2007

Detailed Description:

The National Institutes of Health (NIH) has recently entered into a Transplant Center Participation Agreement with the National Marrow Donor Program® (Registered Trademark) (NMDP). This agreement allows any NIH investigator with an NIH Institutional Review Board (IRB) approved protocol to secure hematopoietic stem cells (HSC) or cord blood units from the NMDP registry for the purpose of transplanting patients who have no suitable matched related donors. As part of an agreement with the NMDP Research Program, the NMDP staff is required to inform patients about this protocol and requires that blood samples as well as baseline and outcome data (mainly demographic, quality of life, and clinical data) be collected and maintained in accordance with the NMDP IRB approved protocols. The goal of the NMDP Research Program is to improve the safety and effectiveness of unrelated donor HSC transplantation for both the donors and recipients, and to have a comprehensive source of data that can be used to study unrelated donor HSC transplantation. The NMDP is the sole custodian of the data in the Research Database.

The primary purpose of this protocol is to incorporate all the NMDP requirements for securing data and blood samples on recipients whose transplant was facilitated by NMDP here at NIH as well as TED (Transplant Essential Data) level data submission for NIAID Allogeneic receipient patients. This protocol will include patients at the NIH that have enrolled in an NIH IRB approved protocol to receive matched unrelated donor (MUD) HSC transplants or cord blood transplants facilitated by the NMDP. It may also include patients that have undergone a MUD transplant at another approved transplant center but need to receive additional blood products from the donor while at NIH after completing a transplant center transfer.

  Eligibility
Ages Eligible for Study:   1 Year to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria
  • INCLUSION CRITERIA:

Patients (Recipient):

Must be enrolled on an NIH IRB approved protocol which involves an HSC transplant or cellular therapy utilizing HSC from an unrelated donor affiliated with the NMDP.

May include recipients who have received an NMDP facilitated HSC transplant at other institutions, provided the patient consents to and completes a Transplant Center transfer.

Ability to comprehend and willing to sign the informed consent or have a parent/guardian consent if the donor is a minor; assent obtained from minors as appropriate.

NIAID Allogeneic (sibling matched) receipients for TED level data submission only.

EXCLUSION CRITERIA:

The patient has received an HSC transplant or cellular therapy utilizing HSC from an unrelated donor facilitated by a registry other than NMDP.

Non-NIAID Allogeneic (sibling matched) Recipients.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00495300

Contacts
Contact: Patient Recruitment and Public Liaison Office     (800) 411-1222     prpl@mail.cc.nih.gov    
Contact: TTY     1-866-411-1010    

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike     Recruiting
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   070183, 07-I-0183
First Received:   June 30, 2007
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00495300
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
HSC/MUD Transplant  
NMDP  
NMDP Data Collection  
NMDP Samples
BMT
Samples

ClinicalTrials.gov processed this record on November 06, 2008




Links to all studies - primarily for crawlers